What Is a Skull Base Chordoma?
A skull base chordoma is a rare type of bone cancer that develops near the base of the skull, where the spine and skull connect. These tumors grow from leftover embryonic tissue that remains in the spine after birth.
Although chordomas usually grow slowly, they can press on important structures such as nerves, blood vessels, the brainstem, and the spinal cord. Because of their location, they may affect vision, facial movement, speech, or swallowing.
The exact cause of skull base chordoma is not known. Most cases happen without a clear risk factor or inherited condition. Researchers continue to study genetic changes linked to these rare tumors.
Symptoms
Symptoms often develop gradually as the tumor grows and puts pressure on nearby nerves and tissues.
Symptoms may include:
- Headaches
- Facial pain or numbness
- Double vision
- Weakness in facial muscles
- Neck pain
- Voice changes
- Difficulty swallowing
- Problems with balance or coordination
How Is It Diagnosed?
Healthcare providers diagnose skull base chordoma using imaging tests and specialized evaluations. Because these tumors are rare and can resemble other bone tumors, diagnosis often involves a team with expertise in skull base conditions.
Testing may include:
- MRI scans
- CT scans
- Neurological exams
- Biopsy to confirm the diagnosis
Special imaging techniques may also help distinguish chordoma from other tumors near the skull base.
How Is It Treated?
Treatment usually focuses on removing as much of the tumor as possible while protecting nearby nerves and brain structures.
Treatment options may include:
- Surgery to remove the tumor
- Proton beam or other targeted radiation therapy
- Radiation before or after surgery in selected cases
- Clinical trials for newer therapies
Chemotherapy is not commonly effective for chordoma. Because these tumors can return after treatment, long-term follow-up imaging is important.
Recovery depends on the tumor’s location, size, and the treatments used. Some patients may continue to need support for swallowing, speech, or nerve-related symptoms during recovery.